Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis||
||144||All||16 Years to 75 Years (Child, Adult, Senior)||NCT00282347||U2970g||LUNAR||January 2006||January 2009||January 2013||January 26, 2006||January 15, 2015||February 23, 2010|
|2||NCT03189017||Active, not recruiting||A Phase I Study of ICP-022 in Subjects||
||64||Male||18 Years to 55 Years (Adult)||NCT03189017||ICP-CL-001||July 3, 2017||February 5, 2018||April 30, 2018||June 16, 2017||March 2, 2018||